“Attenuating Renal Interstitial Fibrosis by Shenqi Pill via Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo”, IJKD, vol. 18, no. 2, pp. 87–98, Jun. 2024, doi: 10.52547/ggc27334.